Portola Pharma (PTLA) Receives CRL from FDA for Andexanet Alfa
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/19/2024
- Nasdaq, S&P tumble as Netflix, chip stocks drag; AmEx boosts Dow
- Sony/Apollo bid for Paramount could be worth as much as $29 billion - Source
- Netflix Q1 earnings top estimates on blowout subscriber growth
- Nasdaq tumbles, Treasuries dip amid earnings, geopolitical crosscurrents
- Gold prices rally past $2,400 on reports of Israel strikes on Iran
- Tritium DCFC Limited (DCFC): Three Australian subsidiaries were determined to be insolvent or likely to become insolvent
- Hasbro (HAS) Announces Resignation of Cynthia Williams, President of Wizards of the Coast and Hasbro Gaming
- Jabil falls after placing CEO on paid leave amid internal investigation
- Frontier Communications (FYBR) says third party had gained unauthorized access to portions of its information technology environment
- Ibotta (IBTA) Prices 6.56M Share IPO at $88/sh
- Midday movers: Netflix, Super Micro fall; Paramount Global gains
- After-hours movers: Netflix, Intuitive Surgical, Nordstrom, KB Home
- Midday movers: Tesla, Blackstone, Las Vegas Sands fall; DR Horton rises
- After-hours movers: Alcoa rises; Equifax and Las Vegas Sands fall
- Midday movers: Travelers, JB Hunt fall; United Airlines rises
Portola Pharma (PTLA) Says IndexXa MAA Accepted for Review in Europe
August 19, 2016 8:31 AM EDTPortola Pharmaceuticals Inc. (Nasdaq: PTLA) announced that the MAA for IndexXa (andexanet alfa; trade name in the United States is AndexXa), a Factor Xa inhibitor antidote, has been submitted to the EMA, completed the validation period, and has been accepted for review. IndexXa is in development for patients treated with a Factor Xa inhibitor when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding and for patients requiring urgent or emergency surgery. Portola is seeking conditional approval of IndexXa in the EU through the centralized procedure. With the acceptance of the... More
Wall St. inches up with energy gain, Wal-Mart
August 18, 2016 7:32 AM EDTBy Caroline Valetkevitch
NEW YORK (Reuters) - U.S. stocks ended up slightly on Thursday as Brent oil's rise above $50 a barrel boosted energy shares and an upbeat outlook lifted Wal-Mart (NYSE: WMT) to a 14-month high.
Wal-Mart rose 1.9 percent to end at $74.30 after the retailer reported a better-than-expected quarterly profit and raised its fiscal-year outlook. The upbeat forecast followed disappointing outlooks from Target (NYSE: TGT) and Lowe's Companies (NYSE: LOW) the previous day.
The energy index jumped 1.8... More
Portola Pharma (PTLA) Drops 21% With Andexanet PDUFA Looming
August 17, 2016 3:29 PM EDTPortola Pharma (NASDAQ: PTLA) declined over 20% and was halted on a limit-down pause Wednesday. The company's andexanet alfa PDUFA is today, August 17, 2016. The PDUFA date is the goal date for the FDA to complete its review of the BLA.
... MorePortola Pharma (PTLA) Halted on LUDP
August 17, 2016 3:14 PM EDTPortola Pharma (NASDAQ: PTLA) Halted on LUDP
... More
